4//SEC Filing
TRV GP IV, LLC 4
Accession 0000950170-25-111457
CIK 0001819133other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:15 PM ET
Size
9.2 KB
Accession
0000950170-25-111457
Insider Transaction Report
Form 4
Third Rock Ventures GP IV, L.P.
10% Owner
Transactions
- Sale
Common Stock
2025-08-22$7.00/sh−302,194$2,115,358→ 15,456,881 total
TRV GP IV, LLC
10% Owner
Transactions
- Sale
Common Stock
2025-08-22$7.00/sh−302,194$2,115,358→ 15,456,881 total
Third Rock Ventures IV, L.P.
10% Owner
Transactions
- Sale
Common Stock
2025-08-22$7.00/sh−302,194$2,115,358→ 15,456,881 total
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
- [F2]These shares are directly held by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV and TRV GP IV LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001688325
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:15 PM ET
- Size
- 9.2 KB